Carcinoid syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
Carcinoid syndrome was first described by Siegfried Oberndorfer, a German [[pathologist]] in 1907. Endocrine related properties of carcinoid syndrome was described by Gosset and Masson in 1914.<ref name="pmid24713679">{{cite journal| author=Tsoucalas G, Karamanou M, Androutsos G| title=The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors. | journal=Ann Gastroenterol | year= 2011 | volume= 24 | issue= 2 | pages= 98-100 | pmid=24713679 | doi= | pmc=PMC3959292 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24713679 }} </ref><ref name="pmid3959292">{{cite journal| author=Swiryn S, Hueter DC| title=The electrocardiogram in esophageal impaction. | journal=JAMA | year= 1986 | volume= 255 | issue= 15 | pages= 2067-8 | pmid=3959292 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3959292 }} </ref>
Carcinoid syndrome was first described by Siegfried Oberndorfer, a German [[pathologist]] in 1907. Endocrine related properties of carcinoid syndrome was described by Gosset and Masson in 1914.<ref name="pmid24713679">{{cite journal| author=Tsoucalas G, Karamanou M, Androutsos G| title=The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors. | journal=Ann Gastroenterol | year= 2011 | volume= 24 | issue= 2 | pages= 98-100 | pmid=24713679 | doi= | pmc=PMC3959292 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24713679  }} </ref>


==Historical Perspective==
==Historical Perspective==

Revision as of 21:41, 2 October 2015

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome historical perspective

CDC on Carcinoid syndrome historical perspective

Carcinoid syndrome historical perspective in the news

Blogs on Carcinoid syndrome historical perspective

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Carcinoid syndrome was first described by Siegfried Oberndorfer, a German pathologist in 1907. Endocrine related properties of carcinoid syndrome was described by Gosset and Masson in 1914.[1]

Historical Perspective

Carcinoid syndrome was first described in 1907 by Siegfried Oberndorfer, a German pathologist at the University of Munich, who coined the term karzinoide, or "carcinoma-like", to describe the unique feature of behaving like a benign tumor despite having a malignant appearance microscopically. The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumors are now known to arise from the enterochromaffin (EC) and enterochromaffin-like (ECL) cells of the gut.[1]

References

  1. 1.0 1.1 Tsoucalas G, Karamanou M, Androutsos G (2011). "The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors". Ann Gastroenterol. 24 (2): 98–100. PMC 3959292. PMID 24713679.

Template:WH Template:WS